Evidence map›Paper›PMID 30376880›Full record

Trial reportTrials2018

A novel integrated dressing to secure peripheral intravenous catheters in an adult acute hospital: a pilot randomised controlled trial.

Nicole Marsh, Emily Larsen, Jodie Genzel, Gabor Mihala, Amanda J Ullman, Tricia Kleidon, Sue Cadigan, Claire M Rickard

Open access · goldAbstract readRandomized Controlled TrialPragmatic Clinical TrialEquivalence Trial
In one paragraph

Trial report in Trials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nicole MarshRoyal Brisbane and Women's Hospital, Herston, QLD, Australia.
Emily LarsenRoyal Brisbane and Women's Hospital, Herston, QLD, Australia.
Jodie GenzelRoyal Brisbane and Women's Hospital, Herston, QLD, Australia.
Gabor MihalaSchool of Nursing and Midwifery, Griffith University, Nathan, QLD, Australia.
Amanda J UllmanRoyal Brisbane and Women's Hospital, Herston, QLD, Australia.
Tricia KleidonAlliance for Vascular Access Teaching and Research Group, Menzies Health Institute Queensland, Brisbane, QLD, Australia.
Sue CadiganRoyal Brisbane and Women's Hospital, Herston, QLD, Australia.
Claire M RickardRoyal Brisbane and Women's Hospital, Herston, QLD, Australia. c.rickard@griffith.edu.au.ORCID http://orcid.org/0000-0002-6341-7415
Griffith University · AURoyal Brisbane and Women's Hospital · AUMenzies School of Health Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe reported incidence of peripheral intravenous catheter (PIV) failure has been as high as 69%. This is in part due to inadequate stabilisation or securement to the skin, which allows micro-motion of the catheter within the vein.

methodsA pilot open randomised controlled trial of 300 patients was conducted in the medical and surgical wards of a large tertiary hospital. A superiority parallel pragmatic design was used. Eligible patients over the age of 16 years were randomised using a centralised service (randomly varied block sizes and 1:1 ratio) to have PIV dressings of either (i) a bordered polyurethane dressing (BPU, standard care) or (ii) the integrated securement device (ISD). Allocation was concealed until entry. The primary outcome of feasibility addressed eligibility, consent, protocol adherence and retention rates. All-cause PIV failure was an additional primary outcome. This was a composite of infection (laboratory-confirmed local or bloodstream infection), occlusion or infiltration, dislodgement, phlebitis and thrombosis. Group comparisons were by proportions, incidence rates per 1000 PIV days and hazard ratios. Secondary outcomes were local or bloodstream infection, occlusion or infiltration, dislodgement, phlebitis, thrombosis, PIV dwell time, safety and adverse events and patient satisfaction with study products. Analysis was by intention to treat and the patient was the unit of measurement. Multivariable modelling was undertaken.

resultsFeasibility outcomes were 91% of screened patients were eligible, 98% of invited patients consented, 100% of randomised participants received the allocated intervention on insertion and 1/300 (< 1%) were lost to follow-up. In total, 792 PIV days were studied. PIV failure occurred in 43/150 BPU patients (29%) and 40/150 ISD patients (27%) (119 vs 93 per 1000 PIV days; incidence rate ratio 0.78, 95% confidence interval, CI 0.50-1.23). In the multivariate model, ISD (hazard ratio 0.51, 95% CI 0.29-0.89) and admission for a surgical emergency were significantly associated with decreased failure, while female gender, wound, hand insertion and more frequent PIV use were significantly associated with increased PIV failure.

conclusionISDs were significantly associated with decreased failure in the multivariable modelling. Feasibility outcomes were supportive of the need to undertake a larger trial to confirm these results.

trial registrationAustralian New Zealand Clinical Trials Registry, ACTRN12616000984493 . Registered 27 July 2016.

Indexed as

Catheters, IndwellingOcclusive DressingsAdultAgedCatheterization, PeripheralData CollectionData Interpretation, StatisticalFeasibility StudiesFemaleHumansMaleMiddle AgedOutcome Assessment, Health CarePilot ProjectsCatheterisation, PeripheralCatheter-Related InfectionsRandomised Controlled Trial, Occlusive Dressings

Identifiers

PMID30376880
PMCPMC6208178
OpenAlexW2898906998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.